Arkolith/Insider Trading/LYEL/Form 4

Innovative Cellular Therapeutics Holdings Ltd

10% OwnerLyell Immunopharma, Inc. (LYEL) · full profile →Form 4 · filed Jul 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$137
Net Open-Market Flow
-$137
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 16, 2026Sell(S)10$13.73$1372.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-028846) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML